These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20323037)

  • 1. The Pharmaceutical Manufacturers' View of Health Insurance.
    Can Med Assoc J; 1944 Mar; 50(3):255. PubMed ID: 20323037
    [No Abstract]   [Full Text] [Related]  

  • 2. Manufacturers' support policies database: updated information.
    Health Devices; 1993 Dec; 22(12):586-9. PubMed ID: 8113072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre validation of manufacturers' weight-based recommendations for laryngeal mask airway size choice in anaesthetic practice: A retrospective analysis of 20,893 cases.
    Avidan A; Eden A; Reider E; Weissman C; Levin PD
    Eur J Anaesthesiol; 2015 Jun; 32(6):432-8. PubMed ID: 25923816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overestimation of stent delivery balloon diameters by manufacturers' compliance tables: a quantitative coronary analysis of Duet and NIR stent implantation.
    Hehrlein C; DeVries JJ; Wood TA; Haller SD; Arab A; Kloostra AC; Lauer MA; Fischell TA
    Catheter Cardiovasc Interv; 2001 Aug; 53(4):474-8; discussion 479. PubMed ID: 11514996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of manufacturers' declarations for lipemia interference--an urgent call for standardization.
    Nikolac N; Simundic AM; Miksa M; Lima-Oliveira G; Salvagno GL; Caruso B; Guidi GC
    Clin Chim Acta; 2013 Nov; 426():33-40. PubMed ID: 23981842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manufacturers' support policies.
    Health Devices; 1992 Sep; 21(9):316-22. PubMed ID: 1428903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of Opening and Closing Angles of Aortic Valve Prostheses In Vivo Using Dual-Source Computed Tomography: Comparison with Those of Manufacturers' in 10 Different Types.
    Suh YJ; Kim YJ; Hong YJ; Lee HJ; Hur J; Im DJ; Kim YJ; Choi BW
    Korean J Radiol; 2015; 16(5):1012-23. PubMed ID: 26356549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring Uncertainty in Economic Evaluations of Drugs and Medical Devices: Lessons from the First Review of Manufacturers' Submissions to the French National Authority for Health.
    Ghabri S; Hamers FF; Josselin JM
    Pharmacoeconomics; 2016 Jun; 34(6):617-24. PubMed ID: 26829942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early benefit assessment of pharmaceuticals in Germany: manufacturers' expectations versus the Federal Joint Committee's decisions.
    Fischer KE; Stargardt T
    Med Decis Making; 2014 Nov; 34(8):1030-47. PubMed ID: 25149822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Color attributes and accuracy of Vita-based manufacturers' shade guides.
    Yap AU
    Oper Dent; 1998; 23(5):266-71. PubMed ID: 9863448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential need for surgeon consensus: Cementation techniques for total knee arthroplasty in orthopedic implant manufacturers' guidelines lack consistency.
    Randall DJ; Anderson MB; Gililland JM; Peters CL; Pelt CE
    J Orthop Surg (Hong Kong); 2019; 27(3):2309499019878258. PubMed ID: 31615344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of benefits and risk information on pharmaceutical web sites for the treatment of menopause.
    Charbonneau DH
    Health Info Libr J; 2013 Sep; 30(3):212-9. PubMed ID: 23981022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to improve pharmaceutical supply chain resilience under politico-economic sanctions: the case of Iran.
    Bastani P; Dehghan Z; Kashfi SM; Dorosti H; Mohammadpour M; Mehralian G; Ravangard R
    J Pharm Policy Pract; 2021 Jul; 14(1):56. PubMed ID: 34225794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.
    Shen AK; Rodewald LE; Birkhead GS
    Pediatrics; 2009 Dec; 124 Suppl 5():S540-7. PubMed ID: 19948586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE AMERICAN PHARMACEUTICAL MANUFACTURERS' ASSOCIATION.
    Science; 1943 Dec; 98(2555):533-4. PubMed ID: 17819394
    [No Abstract]   [Full Text] [Related]  

  • 16. Arbitration Board Setting Reimbursement Amounts for Pharmaceutical Innovations in Germany When Price Negations between Payers and Manufacturers Fail: An Empirical Analysis of 5 Years' Experience.
    Ludwig S; Dintsios CM
    Value Health; 2016 Dec; 19(8):1016-1025. PubMed ID: 27987628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual pharmaceutical manufacturers' directory--1990.
    Canizares E
    Hosp Pharm; 1990 Jan; 25(1):11-6. PubMed ID: 10106365
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical manufacturers' plans.
    KLUMPP T
    Am J Pharm Sci Support Public Health; 1952 Jul; 124(7):215-22. PubMed ID: 14952561
    [No Abstract]   [Full Text] [Related]  

  • 19. Hospital-based training for pharmaceutical manufacturers' representatives.
    Powell SH; Stempien MJ; Vogenberg FR
    Am J Hosp Pharm; 1984 Jan; 41(1):70, 74. PubMed ID: 6695935
    [No Abstract]   [Full Text] [Related]  

  • 20. Introduction and the PACS '82 panel discussions: Panel 1--Equipment manufacturers' view on PACS and Panel 2--The medical community's view on PACS. 1982.
    Duerinckx AJ
    J Digit Imaging; 2003 Mar; 16(1):32-68; discussion 29-31. PubMed ID: 12945814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.